ArticleTherapeutic advances in medical oncology2025

Real-world comparison of flumatinib and nilotinib as first-line therapy for patients with chronic phase chronic myeloid leukemia: a multicenter retrospective study.

Yutian Lei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.